mycinamicin IV

[(2R,3R,4E,6E,9R,11S,12S,13S,14E)-2-ethyl-9,11,13-trimethyl-8,16-dioxo-12-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}oxacyclohexadeca-4,6,14-trien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-β-D-allopyranoside

DBTIHDIIXPQOFR-JMHKOBKLSA-N CHEBI:63284 0 Reactome links 2 studies

Metabolite details

Identifier: DBTIHDIIXPQOFR-JMHKOBKLSA-N
InChI Key: DBTIHDIIXPQOFR-JMHKOBKLSA-N
IUPAC name: [(2R,3R,4E,6E,9R,11S,12S,13S,14E)-2-ethyl-9,11,13-trimethyl-8,16-dioxo-12-{[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy}oxacyclohexadeca-4,6,14-trien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-β-D-allopyranoside
Preferred name: mycinamicin IV
INN name: —
Synonym: —
ChEBI: CHEBI:63284

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
Brain metabolomic profiling of eastern honey bee (Apis cerana) infested with the mite Varroa destructor.

Observed in differential profiles

Wild_type_vs_hfq
Mite_Infestation_vs_Control
Mite_Infestation_vs_Control